Work

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

Year: 2003

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/sj.leu.2402803

Authors: E Feldman, M Kalaycio, G Weiner, S Frankel, P Schulman, L Schwartzberg, J Jurcic, E Velez-Garcia, K Seiter, D Scheinberg, D Levitt, N Wedel

Institutions: New York Medical College, Cleveland Clinic, University of Iowa, University of Iowa Holden Comprehensive Cancer Center, North Shore University Hospital, Memorial Sloan Kettering Cancer Center, University of Puerto Rico, Medical Sciences Campus, University of Puerto Rico System, PDL BioPharma (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2016103085

FWCI: 3.962

Cites: 23

Cited by: 84

Related to: 10